Table 1 Subject characteristics.
| Â | Nondilated | Aneurysm | P value |
|---|---|---|---|
n = 17 | n = 18 | ||
Age (years) | 48.6 ± 18.4 | 62.7 ± 11.0 | 0.0273 |
Sex (male) | 11 (65%) | 16 (89%) | 0.1212 |
Race | |||
   African American | 4 (24%) | 0 (0%) | 0.0299 |
   Caucasian | 9 (53%) | 16 (89%) | |
   Hispanic | 4 (24%) | 2 (11%) | |
Body surface area (m2) | 1.98 ± 0.24 | 2.06 ± 0.29 | 0.2584 |
Aorta diameter (cm) | 3.18 ± 0.40 | 5.19 ± 0.46 | < 0.0001 |
Aorta z-score | − 0.25 ± 1.04 | 5.56 ± 1.77 | < 0.0001 |
Bicuspid aortic valve | 1 (6%) | 9 (50%) | 0.0072 |
Aortic valve insufficiency | 0 (0%) | 11 (61%) | 0.0001 |
Aortic valve stenosis | 1 (6%) | 4 (22%) | 0.3377 |
Aortic atherosclerosis | 5 (29%) | 1 (6%) | 0.0877 |
Hypertension | 6 (35%) | 12 (67%) | 0.0943 |
Hyperlipidemia | 2 (12%) | 12 (67%) | 0.0016 |
Diabetes mellitus | 2 (12%) | 3 (17%) | > 0.99 |
Smoking | 12 (71%) | 7 (39%) | 0.0922 |
Lipid lowering agents | 3 (18%) | 14 (78%) | 0.0006 |
Beta blockers | 5 (29%) | 9 (50%) | 0.3053 |
Calcium channel blockers | 1 (6%) | 3 (17%) | 0.6026 |
ACEI/ARB | 3 (18%) | 7 (39%) | 0.2642 |